Printer Friendly
The Free Library
19,585,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Biopharma Deal Making: A Focus On Sensory Organ/Oral Health.


DUBLIN Dublin, city, Republic of Ireland
Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River.
, Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles.  -- Research and Markets (http://www.researchandmarkets.com/reports/c45841) has announced the addition of Partneringreview 2006: Biopharma Deal Making By Therapy Area - Sensory sensory /sen·so·ry/ (sen´sor-e) pertaining to sensation.

sen·so·ry
adj.
1. Of or relating to the senses or sensation.

2.
 Organ/Oral Health to their offering.

This report contains a subset A group of commands or functions that do not include all the capabilities of the original specification. Software or hardware components designed for the subset will also work with the original.  of the data provided in "PartneringReview 2006: BioPharma Deal Making ", which is a comprehensive summary of the years BioPharma deals, providing a broad perspective of the deal making activity during 2005:

* Want to know what your competitors are doing?

* Want to benchmark your deals against others in your therapeutic area?

* See how the finances of different deal types compare?

* Want to know what the early, clinical and late stage developments are?

* Interested in new merger and acquisition activity over 2005?

* Curious about financing investments from lead investors?

PartneringReview 2006: BioPharma Deal Making provides:

* Fully categorized cat·e·go·rize  
tr.v. cat·e·go·rized, cat·e·go·riz·ing, cat·e·go·riz·es
To put into a category or categories; classify.



cat
 overviews of deals, alliances and financings

* Financial information where disclosed

* Specialized spe·cial·ize  
v. spe·cial·ized, spe·cial·iz·ing, spe·cial·iz·es

v.intr.
1. To pursue a special activity, occupation, or field of study.

2.
 indexes including deal type, therapy area, industry sector, financials and stage of development

* An alphabetical index of company activity

* Interactive PDF (Portable Document Format) The de facto standard for document publishing from Adobe. On the Web, there are countless brochures, data sheets, white papers and technical manuals in the PDF format.  format for easy exploration

This section of the report provides an in depth view into the Sensory Organ and Oral Health focused deals and alliances announced in 2005, in a clear and accessible format.

The report analyzes deals announced by company, industry focus, and development stage. Every deal is fully categorized, includes a detailed description mentioning the sensory/dental disease being treated, and includes financials such as headline value, upfront and milestone payments, where disclosed.

Each deal is annotated with a deal number, such as #43. This number links to the full deal in the deal listing at the rear of each report.

For more information visit http://www.researchandmarkets.com/reports/c45841

Laura Wood

Senior Manager

Research and Markets

press@researchandmarkets.com

Fax: +353 1 4100 980
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 23, 2006
Words:291
Previous Article:Research and Markets: Unilog is Major Provider of Electronics Manufacturing Services, Investment and Other Products.
Next Article:Aviation Industry's Recovery Drives Demand for Commercial Aircrafts and Engine MRO.
Topics:



Related Articles
DOR BioPharma Announces Publication of Article Concerning Ricin Mutants in Nature Biotechnology.
DOR BioPharma Appoints Geoff Green as Vice President of Clinical Operations; Newly Created Position To Spearhead orBec Clinical Trial Program.
Pressure-specifying sensory device: quantitative sensory measurement in the oral cavity and oropharynx of normal adults.
Organ of Chievitz.
DOR's Abstract Describing orBec Phase III Clinical Trial Results Selected for Presentation at the Annual Meeting of the American Association of...
DOR BioPharma to File NDA for orBec'R'.
Merrion Biopharma Appoints Jonathan O'Connell as Chief Financial Officer.
Biopharma Deals 2006: Focus on Metabolic Diseases.
Biopharma Deal Making: A Focus On Genitourinary/Gynecology.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles